Alrex
NDC 54868-4277
Product Information
Alrex is a NDA-approved product labeled by Physicians Total Care, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 54868-4277 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 54868-4277?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LOTEPREDNOL ETABONATE (UNII: YEH1EZ96K6)
- LOTEPREDNOL (UNII: Z8CBU6KR16) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- GLYCERIN (UNII: PDC6A3C0OX)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- POVIDONE (UNII: FZ989GH94E)
- WATER (UNII: 059QF0KO0R)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- TYLOXAPOL (UNII: Y27PUL9H56)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 213262 - Alrex 0.2 % Ophthalmic Suspension
- RxCUI: 213262 - loteprednol etabonate 2 MG/ML Ophthalmic Suspension [Alrex]
- RxCUI: 213262 - Alrex 2 MG/ML Ophthalmic Suspension
- RxCUI: 311381 - loteprednol etabonate 0.2 % Ophthalmic Suspension
- RxCUI: 311381 - loteprednol etabonate 2 MG/ML Ophthalmic Suspension
* Please review the full disclaimer at the bottom of this page.